Ftse Mib
35.398,82
-0,03%
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
NASDAQ
16.685,97
-0,07%
Bitcoin
66.936,42
-0,22%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Allena Pharmaceuticals Inc (ALNA) Allena Pharmaceuticals Inc (ALNA) Notizie

ALNA

Allena Pharmaceuticals (ALNA)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ALNA
DataOraFonteTitoloSimboloCompagnia
14/11/202222:04Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:ALNAAllena Pharmaceuticals Inc
14/09/202215:53Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:ALNAAllena Pharmaceuticals Inc
07/09/202222:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ALNAAllena Pharmaceuticals Inc
13/07/202222:12Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ALNAAllena Pharmaceuticals Inc
12/07/202222:05GlobeNewswire Inc.Allena Pharmaceuticals Announces New Meeting Date and New Record Date for Special Meeting to Approve Reverse Stock SplitNASDAQ:ALNAAllena Pharmaceuticals Inc
11/07/202214:53Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ALNAAllena Pharmaceuticals Inc
05/07/202213:00GlobeNewswire Inc.Allena Pharmaceuticals Announces Rescheduling of Special Meeting to Approve Reverse Stock SplitNASDAQ:ALNAAllena Pharmaceuticals Inc
23/06/202222:46Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:ALNAAllena Pharmaceuticals Inc
24/05/202214:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ALNAAllena Pharmaceuticals Inc
17/05/202221:44Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ALNAAllena Pharmaceuticals Inc
17/05/202215:55TipRanksAllena Pharmaceuticals (ALNA) Receives a Hold from H.C. WainwrightNASDAQ:ALNAAllena Pharmaceuticals Inc
16/05/202222:26Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ALNAAllena Pharmaceuticals Inc
13/05/202222:10Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ALNAAllena Pharmaceuticals Inc
02/02/202222:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALNAAllena Pharmaceuticals Inc
25/01/202222:06Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ALNAAllena Pharmaceuticals Inc
05/01/202217:35TipRanksAllena Pharmaceuticals (ALNA) Receives a Buy from B.Riley FinancialNASDAQ:ALNAAllena Pharmaceuticals Inc
05/01/202212:25TipRanksAnalysts’ Top Healthcare Picks: Allena Pharmaceuticals (ALNA), Unity Biotechnology (UBX)NASDAQ:ALNAAllena Pharmaceuticals Inc
12/11/202122:14Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:ALNAAllena Pharmaceuticals Inc
12/11/202122:08Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ALNAAllena Pharmaceuticals Inc
03/11/202113:45Dow Jones NewsAllena Pharmaceuticals Gets Fast Track Designation for Kidney Disease TreatmentNASDAQ:ALNAAllena Pharmaceuticals Inc
13/08/202113:33TipRanksAllena Pharmaceuticals: a Penny Stock with PotentialNASDAQ:ALNAAllena Pharmaceuticals Inc
08/06/202114:30GlobeNewswire Inc.Allena Pharmaceuticals to Host Key Opinion Leader Webinar Focused on ALLN-346 for the Treatment of Gout in Patients with Chro...NASDAQ:ALNAAllena Pharmaceuticals Inc
11/05/202114:00GlobeNewswire Inc.Allena Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business UpdateNASDAQ:ALNAAllena Pharmaceuticals Inc
06/05/202122:57Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ALNAAllena Pharmaceuticals Inc
04/05/202122:01GlobeNewswire Inc.Allena Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:ALNAAllena Pharmaceuticals Inc
08/04/202120:14Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ALNAAllena Pharmaceuticals Inc
07/04/202114:00GlobeNewswire Inc.Allena Pharmaceuticals Appoints Mark J. Fitzpatrick to its Board of DirectorsNASDAQ:ALNAAllena Pharmaceuticals Inc
11/03/202113:39Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ALNAAllena Pharmaceuticals Inc
11/03/202113:17Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ALNAAllena Pharmaceuticals Inc
09/03/202113:00GlobeNewswire Inc.Allena Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business UpdateNASDAQ:ALNAAllena Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ALNA

La tua Cronologia

BOV
MBLY3Q
Mobly ON
USOTC
FALC
FalconStor Software (PK)
NASDAQ
IGABFX
Large Cap Core Strategy ...
BIT
I05736
Banca Imi
NYSE
SCVX.U
SCVX
LSE
SOS
Sosandar
KOSPI
175330
JB Financial
COIN
WBETHUST
Wrapped Binance Beacon ETH
OKEX
TMTGUSDT
BOV
AFHI11
AF Invest CRI Fundo DE I...
BIT
P15YS3
BNP Paribas Issuance
BIT
P1CSG6
BNP Paribas Issuance
BOV
ITSA3
ITAUSA ON
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network